glp-1 and ghrelin Glucagon-Like Peptide-1: A Gut-Brain Axis Battle for Food Reward Ghrelin, CCK, GLP-1, and PYY(3–36):

In summary, we provide initial real-world evidence of reduced alcohol consumption in people with obesity taking Semaglutide or Tirzepatide medications, suggesting potential efficacy for treatment in AUD comorbid with obesity. Note: Beyond what is publicly available today, several studies from established research groups showing substantial anti-addictive effects have been submitted to journals and will be published in mid-2024

Lixisenatida en pacientes con diabetes tipo 2 y obesidad: ms all del control glucmico

This is still rare, but one to know and triage promptly if severe, persistent abdominal pain and bloating occur

Kalp arpnts, nefes darl yaadm ve son 2 gndr neredeyse hi uyuyamadm

It calms overactive immune responses at the mucosal level, supporting gut barrier repair and reducing the inflammatory signaling that drives skin and digestive symptoms

Common early side effects include constipation , nausea, and reduced appetite